Dionex Corporation to Present at the UBS Global Life Sciences Conference
637446
SUNNYVALE, Calif., Sept. 20  /PRNewswire-FirstCall/ -- Dionex Corporation  announced today that it will present at the UBS Global Life Sciences Conference on Thursday, September 28, 2006 at 10:30 a.m. (Eastern Time).  Dr.
70832
WHAT:  VeriSign and LogLogic will be presenting a joint online event that highlights the importance of effective log data management and intelligence in payment networks. The live webcast will be broadcast on September 27, 2006 at 2:00pm ET.
214879
DUBLIN -- US drug company Biogen Idec is considering an all-share bid of more than 8.5 billion euros ($10.6 billion) for Irish peer Elan , a newspaper reported yesterday.
665690
The developing biopharmaceutical company announces a share offering.
640519
Metabolix, Inc. (NASDAQ: MBLX), a company developing and commercializing  environmentally sustainable and totally biodegradable MirelTM  natural plastic, today announced that it will be presenting  at the Piper Jaffray & Co. Consumer Conference taking place on June 6 --  7,2007 in New York City.
409761
Genzyme shows some sparkle at investors' conference.
401140
A small Rockville biotech company, started by a former government scientist 10 years ago to take on the global problem of tuberculosis, plans to announce today a significant step forward for a drug at the center of its business.
466497
Adnexus Therapeutics Inc., an ambitious young biotech company in Waltham, says it is going public.
385741
Connotate Technologies, Inc. President and Chief Executive Officer Bruce  Molloy will speak at the Goldman Sachs 8th  Annual Global Internet Conference in Las Vegas on Thursday, May 24,  2007.
524340
NEW YORK, September 1 (New Ratings) - Boston Scientificâs (BSX.NYS) share price rose more than 6% on the news of market share regains by Taxus, the company&#39;s drug-coated stent.
704846
Celanese Corporation (NYSE:CE), a global hybrid chemical company, today announced that David N. Weidman, president and chief executive officer, will address investors at the Bank of America 36th Annual Investment Conference on Monday, September 18 at 2:00 p.m. Pacific Time in San Francisco.
419598
Where is pharmaceutical company Onyx headed?
279752
NEW YORK, December 3  - Biomiraâs (BIOM.NAS) share price appreciated 94% in mid day trade on the NASDAQ today, after the Canadian biotech company, along with its German development partner, Merck KgaA (MRK), reported promising test
215928
SEPTEMBER 28, 2004  - Corporate users facing mandates to adopt radio frequency identification technology will get a chance at this week&#39;s EPCglobal US Fall Conference in Baltimore to gauge how much progress vendors, service providers
277235
BOSTON, Jan. 31  /PRNewswire/ -- Color Kinetics Incorporated  today announced that President and CEO Bill Sims will present at the 2007 Deutsche Bank Small Cap Growth Conference in Naples, Florida on February 13.
254969
CEOs in the life-sciences business are supposed to be sober, scientifically grounded leaders. So, when Josh Boger, chief executive of Vertex Pharmaceuticals Inc. , showed a slide last year comparing one of the drugs his Cambridge company is developing to Apple's iPod, he raised a lot of eyebrows.
766094
DUBLIN/NEW YORK  - Patients taking an experimental  multiple sclerosis drug developed by Biogen Idec Inc. BIIB.O  and Elan Corp. ELN.I experienced far fewer relapses in a  clinical trial, data that analysts say could give the drug a  dominant market position.